[1] |
WANG Li, YU Wenwen, LI Min, GUO Ruihui, CAO Guangsheng, QI Yingmei.
Risk factors and precautions for adverse drug reactions caused by Digoxin
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1269-1272.
|
[2] |
SU Su, WU Shiqi, ZHANG Qingxia, YAN Suying.
Pharmaceutical care of a patient with indapamide-induced agranulocytosis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1282-1285.
|
[3] |
YANG Caihua, YANG Longna, LI Xiaobo.
Two cases of fetal malformation after exposure to low dose warfarin sodium tablets in early pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1286-1289.
|
[4] |
ZHANG Wenwen, NIE Xiting, XU Huiru, RAN Ye, TIAN Chenglin, YU Shengyuan.
One case of extremely abnormal coagulation caused by warfarin combined with compound paracetamol and amantadine hydrochloride tablets
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1290-1292.
|
[5] |
XIE Jing, GUAN Fei.
One case of spontaneous hemorrhage of iliopsoas and gluteal muscles induced by drugss
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1299-1302.
|
[6] |
ZHAO Rui, YU Xiaojia, AN Zhuoling.
Pharmaceutical care of one case of luminous phenomena induced by high-dose amiodarone
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1173-1175.
|
[7] |
ZHANG Qing, ZHU Lei, LIN Cunlian, XIE Peitao, YANG Junli, SU Changhai.
Psoriasis aggravated by labetalol during pregnancy: a case report
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1060-1063.
|
[8] |
SA Rina, ZHANG Bing, LIN Zhijian, ZHANG Xiaomeng, WANG Yu.
Therapeutic effect of saffron against arrhythmia induced by doxorubicin in rats
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 848-857.
|
[9] |
YIN Yuling, HU Chujuan, ZHANG Xiaomeng, WANG Yu, ZHANG Bing, LIN Zhijian.
Mining and validation of anti-adriamycin cardiotoxic effect of chicory extract
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 858-865.
|
[10] |
MENG Kangkang, LIU Saiyue.
After-marketing safety of coenzyme Q10 for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 795-798.
|
[11] |
DING Qian, LI Boyu, ZHANG Qingxia.
Risks to storage of nitroglycerin after unsealing and ways of prevention
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 326-330.
|
[12] |
ZHANG Yuan, HE Mei.
Pharmaceutical care for a case of Parkinson's syndrome caused by trimetazidine hydrochloride tablets in an elderly patient with renal insufficiency
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 343-345.
|
[13] |
CAI Yuluo, GUO Jiahui, Wang Xinguo, TIAN Yilong, WANG Meng, NIU Liying, LI Junshan.
Research progress in Yi medicine Valeriana jatamans and predictive analysis of related quality markers
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 348-352.
|
[14] |
DING Qian, LI Boyu, ZHANG Qingxia.
Analysis of one case of hemorrhagic goiter caused by aspirin tablets in one patient with coronary heart disease
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 209-212.
|
[15] |
FAN Leilei, YANG Jing, XIAO Qianqian, GAO Dongxue, QU Suping.
Comparison of the effects of carvedilol and metoprolol on myocardial infarction and cardiac function in hemodialysis patients
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1338-1343.
|